FDA 483 - Prescription Labs Inc dba Greenpark - October 27, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On October 27, 2017, the FDA issued a Form 483 to Prescription Labs, Inc. dba Greenpark Compounding Pharmacy, located at 4061 Bellaire Blvd., Houston, TX 77025-1121, following an inspection from October 16-20, 23-24, and 27, 2017. The firm is a producer of sterile and non-sterile drugs.
The inspection revealed six observations related to aseptic processing and quality control:
1. **Aseptic Processing Personnel:** On October 17, 2017, an operator performing aseptic processing was observed with partially exposed skin on their upper torso inside the ISO 5 area, while wearing a non-sterile mask, goggles, and hairnet. 2. **Gloved Hand Sanitization:** On October 17, 2017, an operator sanitized gloved hands with non-sterile solution before resuming aseptic processing in the ISO 5 area. 3. **Disinfecting Wipes:** Wipes used for disinfecting the interior of the ISO 5 hood were not sterile. 4. **ISO 5 Area Certification:** The ISO 5 classified areas were not certified under dynamic conditions, specifically, unidirectional air flow was not verified under operational conditions. 5. **Sterility Testing:** There was no evidence of
ID · 0d525240-a35e-4253-a840-800ed02c84bd